Pharmaceutical Research

, Volume 14, Issue 1, pp 108–111

Near-Infrared Spectroscopy as a Nondestructive Alternative to Conventional Tablet Hardness Testing

  • Karen M. Morisseau
  • Christopher T. Rhodes


Purpose. Near-infrared reflectance Spectroscopy (NIRS) was used to evaluate and quantify the effect of compression force on the NIR spectra of tablets.

Methods. Flat, white tablets with no orientation (scoring, etc.) were manufactured on a Stokes Rotary Tablet Press. NIRS was used to predict tablet hardness on the following four formulations and one placebo matrix: hydrochlorothiazide (HCTZ) 15% and 20% in a placebo matrix (microcrystalline cellulose and magnesium stearate), and chlorpheniramine maleate (CTM) 2% and 6% in a placebo matrix. Five or six levels of tablet hardness from 2 to 12 kg were used for each formulation. Laboratory hardness data was compared to NIR reflectance data using a NIRSystems Rapid Content Analyzer®. Multiple linear regression and partial least squares regression techniques were used to determine the relationship between tablet hardness and NIRS spectra.

Results. An increase in tablet hardness produced an upward shift (increase in absorbance) in the NIRS spectra. A series of equations was developed by calibrating tablet hardness data against NIR reflectance response for each formulation. The results of NIRS hardness prediction were at least as precise as the laboratory hardness test (SE = 0.32).

Conclusions. A NIRS method is presented which has the potential as an alternative to conventional hardness testing of tablets.

near-infrared Spectroscopy NIRS tablet hardness compression force Rapid Content Analyzer calibration 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    P. Corti, et al. Pharm. Acta Helv 65:28 (1990).Google Scholar
  2. 2.
    M. S. Kamat, R. A. Lodder, and P. P. DeLuca. Pharm. Res. 6:961 (1989).PubMedGoogle Scholar
  3. 3.
    J. A. Ryan, et al. J. Pharm. Biomed. Anal. 9:303 (1991).PubMedGoogle Scholar
  4. 4.
    S. S. Sekulic, et al. Anal. Chem. 68:509–513 (1996).Google Scholar
  5. 5.
    J. K. Drennen and R. A. Lodder. J. Pharm. Sci. 79:622, (1990).PubMedGoogle Scholar
  6. 6.
    B. R. Buchanan, et al. Pharm. Res. 13:616–621 (1996).PubMedGoogle Scholar
  7. 7.
    E. W. Ciurczak, R. P. Torlini, and M. P. Demkowicz. Spectroscopy 1:36–39 (1986).Google Scholar
  8. 8.
    K. M. Morisseau and C. T. Rhodes. Drug Dev. Ind. Pharm. 21:1071–1090 (1995).Google Scholar
  9. 9.
    P. K. Aldridge, et al. Appl. Spectr. 48:1272–1276 (1994).Google Scholar
  10. 10.
    American Society for Testing and Materials. Standard Practices for Infrared, Multivariate, Quantitative Analysis. Official ASTM Publication No. E1655, Philadelphia, PA, 1995, pp. 1–25.Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • Karen M. Morisseau
    • 1
  • Christopher T. Rhodes
    • 1
  1. 1.Applied Pharmaceutical SciencesUniversity of Rhode IslandKingston

Personalised recommendations